W3C home > Mailing lists > Public > public-semweb-lifesci@w3.org > August 2008

[Fwd: Transinsight press release - Abcam and Transinsight agree on collaboration in the area of semantic search technologies for finding antibodies]

From: M. Scott Marshall <marshall@science.uva.nl>
Date: Fri, 15 Aug 2008 17:29:31 +0200
Message-ID: <48A5A0DB.7060005@science.uva.nl>
To: W3C HCLSIG hcls <public-semweb-lifesci@w3.org>
FYI  -Scott


attached mail follows:


TI
_______________________________________________________________________________________________________________________________________________________________

EN Transinsight press release


*Abcam and Transinsight agree on collaboration in the area of semantic
search technologies for finding antibodies*

Cambridge, UK / Dresden, Germany - 13th August 2008
/
Abcam, a bioscience company specialising in the supply of antibodies
from a web-based catalogue and Transinsight, a specialist in semantic
search technologies are pleased to announce a collaboration in the field
of protein information quality control using bioinformatics workflows./

Accurately compiling all the required information around antibody
targets is a challenging task, which has created the requirement for an
automated intelligent computer-based solution to ensure top-quality
information content about proteins. For example, an average human gene
name has 6 or 7 synonyms and many more spelling variants. Hand-curated
databases do not cover all possible ways of naming and spelling genes
and hand-curation is a tedious, error prone and labour-intensive task.

"Until recently there were only limited software tools and scientific
workflows available to help us automatically produce high quality data
sets surrounding each of Abcam's thousands of antibody targets. We need
these data sets to help our customers find the right products", says Dr.
Harter, Senior Business Development Manager at Abcam. Harter continues
"We were looking for solutions for supporting our team of experts and
were impressed by the advanced technologies of Transinsight. The fact
that the company operates the semantic search engine GoPubMed.org and
has extensive bioinformatics and protein databases expertise made the
decision to work with Transinsight easy."

The award winning technology behind GoPubMed fully automates very
difficult analyses normally done by scientists with equal or better
performance, predicting the necessary information by sophisticated
algorithms. "It is good to see how we can significantly enhance our
customers' performance by improving their data quality and thus freeing
their staff from an unnecessary burden" says Michael R. Alvers, CEO at
Transinsight.

*About Abcam*
Abcam plc is a producer and distributor of research-grade antibodies and
associated products headquartered in Cambridge, UK, with a US office
located in Cambridge, Massachusetts and a Japan office located in Tokyo.
The Company produces and distributes its own and third party produced
antibodies to academic and commercial customers throughout the world
with product information and ordering available through the Company's
website, www.abcam.com. Abcam's vision is to build the largest online
catalogue of the best antibodies in the world.

*About Transinsight*
Transinsight develops knowledge-based semantic solutions in the Life
Sciences. Their flagship products www.Go3R.org and www.GoPubMed.com,
renowned biomedical search engines, are the first knowledge-based search
systems of the next generation for the Life Sciences on the internet. In
acknowledgement of the technologies developed by the company,
Transinsight has repeatedly been honoured with international awards. The
firm works in close collaboration with the Dresden University of
Technology. Selected customers are: Unilever, BASF, BfR, StatoilHydro,
Wintershall, Abcam and EMBL. For further information on Transinsight on
the internet, see www.transinsight.com.

To unsubscribe send a blank email to Transinsight press release
unsubscribe <mailto:info@transinsight.com?subject=UNSUBSCRIBE>

--
Transinsight GmbH
Tatzberg 47-51
D-01307 Dresden, Germany

Tel: +49 351 796 57 80
Web: http://www.transinsight.com

CEO/Geschäftsführer Dr. Michael R. Alvers
HRB 24231, Amtsgericht Dresden
Received on Friday, 15 August 2008 15:30:07 GMT

This archive was generated by hypermail 2.3.1 : Tuesday, 26 March 2013 18:00:53 GMT